10-03-2025 |
PM |
|
LFMD |
LifeMD, Inc. |
209.20 |
-0.02 |
-0.05 |
-0.12 |
LifeMD beats top-line and bottom-line estimates; initiates Q1 and FY25 outlook [3/11/2025 12:52 AM] |
5.60 |
1.33 (31.04%) |
5.37 |
1.11 (25.77%) |
3.99 - 12.88 |
6,527,802 |
1,760,000 |
475,290 |
|
|
07-11-2024 |
AH |
|
LFMD |
LifeMD, Inc. |
192.09 |
-0.14 |
-0.09 |
-0.20 |
LifeMD Non-GAAP EPS of $0.14 beats by $0.07, revenue of $53.4M misses by $0.4M [11/7/2024 5:04 PM] |
5.87 |
0.74 (14.33%) |
5.40 |
0.27 (5.26%) |
3.99 - 12.88 |
1,667,120 |
460,000 |
2,661 |
|
|
07-08-2024 |
AH |
|
LFMD |
LifeMD, Inc. |
278.69 |
-0.19 |
-0.13 |
-0.23 |
LifeMD Non-GAAP EPS of $0.06 beats by $0.02, revenue of $50.66M beats by $2.49M [8/7/2024 5:39 PM] |
5.21 |
-0.16 (-2.98%) |
5.15 |
-0.22 (-4.10%) |
3.45 - 12.88 |
1,227,028 |
560,000 |
12,504 |
|
|
08-05-2024 |
AH |
|
LFMD |
LifeMD, Inc. |
502.15 |
-0.19 |
-0.13 |
-0.15 |
LifeMD Non-GAAP EPS of $0.01 beats by $0.02, revenue of $44.14M beats by $1.55M [5/8/2024 5:03 PM] |
9.33 |
-3.00 (-24.33%) |
10.89 |
-1.44 (-11.68%) |
1.59 - 12.88 |
3,302,871 |
710,000 |
43,962 |
|
|
11-03-2024 |
AH |
|
LFMD |
LifeMD, Inc. |
300.03 |
-0.12 |
-0.14 |
-0.40 |
LifeMD Non-GAAP EPS of $0.15 beats by $0.12, revenue of $44.86M beats by $4.37M [3/11/2024 4:27 PM] |
8.38 |
0.42 (5.35%) |
8.30 |
0.35 (4.40%) |
1.14 - 9.11 |
2,263,082 |
600,000 |
93,059 |
|
|
08-11-2023 |
AH |
|
LFMD |
LifeMD, Inc. |
263.40 |
-0.20 |
-0.18 |
-0.03 |
LifeMD, Inc. Non-GAAP EPS of $0.08 beats by $0.05, revenue of $38.6M beats by $0.43M [11/8/2023 4:59 PM] |
6.84 |
-0.32 (-4.47%) |
7.35 |
0.19 (2.65%) |
1.14 - 7.77 |
1,456,066 |
500,000 |
19,852 |
|
|
09-08-2023 |
AH |
|
LFMD |
LifeMD, Inc. |
127.05 |
-0.23 |
-0.09 |
-0.22 |
LifeMD, Inc. Non-GAAP EPS of $0.05, revenue of $35.9M [8/9/2023 5:12 PM] |
4.40 |
0.74 (20.22%) |
3.90 |
0.24 (6.56%) |
1.14 - 5.45 |
935,295 |
310,000 |
6,357 |
|
|
12-05-2023 |
PM |
Before the open (May 12) |
LFMD |
LifeMD, Inc. |
55.80 |
-0.15 |
0.00 |
-0.25 |
LifeMD, Inc. Non-GAAP EPS of $0.06, revenue of $33M beats by $2.19M [5/12/2023 9:24 AM] |
1.82 |
-0.01 (-0.55%) |
1.88 |
0.05 (2.73%) |
1.14 - 3.22 |
437,628 |
50,000 |
34,663 |
|
|
22-03-2023 |
AH |
4:05 PM ET (Mar 22) |
LFMD |
LifeMD, Inc. |
58.18 |
-0.40 |
0.00 |
-0.29 |
LifeMD Non-GAAP EPS of $0.02, revenue of $28.12M misses by $5.46M [3/23/2023 2:17 PM] |
1.45 |
0.05 (3.57%) |
1.50 |
0.10 (7.14%) |
1.14 - 3.89 |
434,520 |
210,000 |
61,461 |
|
|
10-11-2022 |
AH |
4:05 PM ET (Nov 10) |
LFMD |
LifeMD, Inc. |
64.07 |
-0.03 |
-0.27 |
-0.36 |
LifeMD Non-GAAP EPS of -$0.03 beats by $0.09, revenue of $31.41M misses by $0.44M [11/10/2022 5:08 PM] |
2.49 |
0.41 (19.61%) |
2.00 |
-0.01 (-0.50%) |
1.80 - 5.40 |
220,578 |
80,000 |
1,002 |
|
|
11-08-2022 |
AH |
4:05 PM ET (Aug 11) |
LFMD |
LifeMD, Inc. |
72.06 |
-0.22 |
-0.23 |
-0.51 |
LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M [8/11/2022 5:50 PM] |
2.90 |
-0.25 (-7.90%) |
3.20 |
0.05 (1.59%) |
1.80 - 9.25 |
321,376 |
140,000 |
12,438 |
|
|
13-05-2022 |
PM |
Before the open (May 13) |
LFMD |
LifeMD, Inc. |
62.73 |
-0.25 |
-0.25 |
-0.38 |
LifeMD Non-GAAP EPS of -$0.25 beats by $0.01, revenue of $29M misses by $2.53M [5/13/2022 8:39 AM] |
2.14 |
0.20 (10.31%) |
2.10 |
0.16 (8.25%) |
1.85 - 16.28 |
110,819 |
130,000 |
779 |
|
|
07-03-2022 |
AH |
4:05 PM ET (Mar 7) |
LFMD |
LifeMD |
103.00 |
-0.29 |
-0.39 |
0.00 |
LifeMD Non-GAAP EPS of -$0.29, revenue of $27.42M [3/7/2022 4:15 PM] |
3.47 |
0.26 (8.10%) |
3.20 |
-0.02 (-0.62%) |
2.72 - 21.95 |
128,737 |
120,000 |
2,122 |
|
|
10-11-2021 |
AH |
4:05 PM ET (Nov 10) |
LFMD |
LifeMD, Inc. |
151.74 |
-0.36 |
-0.49 |
-1.65 |
LifeMD EPS beats by $0.26, misses on revenue [11/10/2021 4:21 PM] |
4.83 |
-0.17 (-3.40%) |
5.40 |
0.40 (8.00%) |
4.50 - 33.02 |
669,405 |
370,000 |
15,356 |
|
|
12-08-2021 |
AH |
4:00 PM ET (Aug 12) |
LFMD |
LifeMD, Inc. |
248.53 |
-0.51 |
-0.45 |
-0.30 |
LifeMD EPS beats by $0.02, beats on revenue [8/12/2021 4:20 PM] |
7.39 |
-1.72 (-18.88%) |
8.02 |
-1.09 (-11.96%) |
4.40 - 33.02 |
1,632,673 |
350,000 |
18,892 |
|
|
13-05-2021 |
AH |
4:05 PM ET (May 13) |
LFMD |
LifeMD, Inc. |
183.42 |
-0.38 |
-0.44 |
-0.25 |
LifeMD EPS beats by $0.21, misses on revenue [5/13/2021 4:31 PM] |
8.79 |
2.28 (35.02%) |
7.30 |
0.79 (12.14%) |
1.35 - 33.02 |
14,305,362 |
800,000 |
158,064 |
|
-
LifeMD EPS beats by $0.21, misses on revenue [5/13/2021 4:31 PM]
-
LifeMD surges 11% as telemedicine provider achieves record revenue [5/14/2021 9:04 AM]
-
LFMD INVESTOR ALERT: Shareholder Lawsuit Filed [May-12-21 12:30PM]
-
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against LifeMD, Inc. (LFMD) [May-13-21 11:00AM]
-
DEADLINE ALERT for LFMD, RMO, and CS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders [May-13-21 12:05PM]
-
LifeMD, Inc. to Host Earnings Call [May-13-21 02:30PM]
-
LifeMD Reports Q1 2021 Revenue up 323% to Record $18.2M, Raises Full Year Revenue Guidance to $90-$100M [May-13-21 04:01PM]
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intrusion, LifeMD, Romeo Power, and Acadia Pharmaceuticals and Encourages Investors to Contact the Firm [May-13-21 10:00PM]
|
29-03-2021 |
AH |
After the close (Mar 29) |
LFMD |
LifeMD, Inc. |
479.61 |
-2.56 |
-0.27 |
-0.05 |
LifeMD EPS of -$2.56 [3/29/2021 4:21 PM] |
16.09 |
-2.78 (-14.73%) |
17.25 |
-1.62 (-8.59%) |
0.99 - 33.02 |
1,655,348 |
730,000 |
5,989 |
|
|